Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia
暂无分享,去创建一个
V. Veverka | P. Man | P. Řezáčová | P. Novák | L. Vrzal | P. Pachl | A. Hnízda | M. Fábry | J. Škerlová | Martina Šinalová
[1] U. Hofmann,et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity , 2016, Nature Genetics.
[2] Preeti,et al. Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach. , 2015, Journal of medicinal chemistry.
[3] V. Beneš,et al. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation , 2015, Haematologica.
[4] Martin Strohalm,et al. Mapping protein structural changes by quantitative cross-linking. , 2015, Methods.
[5] T. Helleday,et al. Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2 , 2015, Nature Communications.
[6] A. Ferrando,et al. Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL , 2015, Nature Medicine.
[7] Jing Ma,et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia , 2015, Nature Communications.
[8] M. Relling,et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] B. Delabarre,et al. Action at a distance: allostery and the development of drugs to target cancer cell metabolism. , 2014, Chemistry & biology.
[10] Jianjun Liu,et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia , 2014, Nature Genetics.
[11] A. Friedler,et al. Allosteric modulation of protein oligomerization: an emerging approach to drug design , 2014, Front. Chem..
[12] B. Vojtesek,et al. The Assembly and Intermolecular Properties of the Hsp70-Tomm34-Hsp90 Molecular Chaperone Complex* , 2014, The Journal of Biological Chemistry.
[13] Jennifer B Dennison,et al. Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.
[14] R. Nussinov,et al. Multiple conformational selection and induced fit events take place in allosteric propagation. , 2014, Biophysical chemistry.
[15] R. Itoh. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II. , 2013, Current medicinal chemistry.
[16] P. L. Ipata,et al. The functional logic of cytosolic 5'-nucleotidases. , 2013, Current medicinal chemistry.
[17] R. Pesi,et al. A native electrophoretic technique to study oligomerization and activity of cytosolic 5′-nucleotidase II , 2013, Analytical and Bioanalytical Chemistry.
[18] Fang Wang,et al. Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation , 2013, Science.
[19] J. Aster,et al. Resistance revealed in acute lymphoblastic leukemia , 2013, Nature Medicine.
[20] W. Evans,et al. Relapse specific mutations in NT5C2 in childhood acute lymphoblastic leukemia , 2013, Nature Genetics.
[21] A. Ferrando,et al. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL , 2013, Nature Medicine.
[22] Uwe Mueller,et al. Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin , 2012, Journal of synchrotron radiation.
[23] Nadezhda T. Doncheva,et al. Topological analysis and interactive visualization of biological networks and protein structures , 2012, Nature Protocols.
[24] Maxim V. Petoukhov,et al. New developments in the ATSAS program package for small-angle scattering data analysis , 2012, Journal of applied crystallography.
[25] Abhishek K. Jha,et al. Full-length human glutaminase in complex with an allosteric inhibitor. , 2011, Biochemistry.
[26] K. Walldén,et al. Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. , 2011, Journal of molecular biology.
[27] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[28] R. Pesi,et al. Active and regulatory sites of cytosolic 5′‐nucleotidase , 2010, The FEBS journal.
[29] R. Nussinov,et al. The origin of allosteric functional modulation: multiple pre-existing pathways. , 2009, Structure.
[30] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[31] T. Carlomagno. Ligand-target interactions: what can we learn from NMR? , 2005, Annual review of biophysics and biomolecular structure.
[32] A. Scaloni,et al. Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily. , 2004, European journal of biochemistry.
[33] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[34] K Henrick,et al. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. , 2004, Acta crystallographica. Section D, Biological crystallography.
[35] András Fiser,et al. ModLoop: automated modeling of loops in protein structures , 2003, Bioinform..
[36] V. Bianchi,et al. Mammalian 5′-Nucleotidases* , 2003, Journal of Biological Chemistry.
[37] Dmitri I. Svergun,et al. PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .
[38] J. Balzarini,et al. Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. , 2003, Biochemical pharmacology.
[39] Ian W. Davis,et al. Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.
[40] B. Mitchell,et al. ATP and phosphate reciprocally affect subunit association of human recombinant High Km 5'-nucleotidase. Role for the C-terminal polyglutamic acid tract in subunit association and catalytic activity. , 2001, European journal of biochemistry.
[41] J. Mackey,et al. Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. , 2001, Blood.
[42] V. Micheli,et al. Cytosolic 5′‐nucleotidase hyperactivity in erythrocytes of Lesch–Nyhan syndrome patients , 2000, Neuroreport.
[43] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[44] S. Inoue,et al. Molecular cloning of human cytosolic purine 5'-nucleotidase. , 1994, Biochemical and biophysical research communications.
[45] M. Turriani,et al. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. , 1994, Archives of biochemistry and biophysics.
[46] D. Svergun,et al. Synchrotron radiation solution X-ray scattering study of the pH dependence of the quaternary structure of yeast pyruvate decarboxylase. , 1992, Biochemistry.
[47] Dmitri I. Svergun,et al. Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .
[48] V. Madrid-Marina,et al. High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. , 1988, The Journal of biological chemistry.
[49] R. Itoh. Studies on some molecular properties of cytosol 5'-nucleotidase from rat liver. , 1982, Biochimica et biophysica acta.
[50] R. Itoh. Regulation of cytosol 5'-nucleotidase by adenylate energy charge. , 1981, Biochimica et biophysica acta.
[51] Alexei Vagin,et al. Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.
[52] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.